Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Boris M. Hogema is active.

Publication


Featured researches published by Boris M. Hogema.


Journal of Biological Chemistry | 2005

cGMP inhibition of Na+/H+ antiporter 3 (NHE3) requires PDZ domain adapter NHERF2, a broad specificity protein kinase G-anchoring protein

Boyoung Cha; Jae Ho Kim; Hans Hut; Boris M. Hogema; Janani Nadarja; Mirza Zizak; Megan E. Cavet; Whaseon Lee-Kwon; Suzanne M. Lohmann; Albert Smolenski; Chung Ming Tse; Chris Yun; Hugo R. de Jonge; Mark Donowitz

Electroneutral NaCl absorption mediated by Na+/H+ exchanger 3 (NHE3) is important in intestinal and renal functions related to water/Na+ homeostasis. cGMP inhibits NHE3 in intact epithelia. However, unexpectedly it failed to inhibit NHE3 stably transfected in PS120 cells, even upon co-expression of cGMP-dependent protein kinase type II (cGKII). Additional co-expression of NHERF2, the tandem PDZ domain adapter protein involved in cAMP inhibition of NHE3, restored cGMP as well as cAMP inhibition, whereas NHERF1 solely restored cAMP inhibition. In vitro conditions were identified in which NHERF2 but not NHERF1 bound cGKII. The NHERF2 PDZ2 C terminus, which binds NHE3, also bound cGKII. A non-myristoylated mutant of cGKII did not support cGMP inhibition of NHE3. Although cGKI also bound NHERF2 in vitro, it did not evoke inhibition of NHE3 unless a myristoylation site was added. These results show that NHERF2, acting as a novel protein kinase G-anchoring protein, is required for cGMP inhibition of NHE3 and that cGKII must be bound both to the plasma membrane by its myristoyl anchor and to NHERF2 to inhibit NHE3.


Frontiers in Bioscience | 2005

Molecular properties and biological functions of cGMP-dependent protein kinase II.

Arie B. Vaandrager; Boris M. Hogema; de Jonge Hr

Type II cGMP-dependent protein kinase (cGK II) is the protein product of one of two genes coding for cGKs in mammalian genomes. cGK II has a domain structure similar to cGK I (alpha or beta) consisting of an N-terminal regulatory domain, which contains a dimerization and an autoinhibitory region, two cGMP-binding domains and a C-terminal catalytic domain. However, the position of the high and low affinity cGMP-binding-domains in cGK II are reversed in comparison to cGK I. Moreover, the isoenzymes exhibit a different affinity towards various membrane permeable cGMP-analogs, allowing differentiation between the cGKs. Type II cGK is bound to the membrane by a myristoyl moiety. It has a distinct function and an expression pattern distinct from that of cGKI, being expressed predominantly in intestine, brain, and kidney. It is involved in regulating electrolyte and water secretion by epithelial tissues in response to the luminocrinic hormones guanylin and uroguanylin and in the secretory diarrhea provoked by heat-stable enterotoxins. Type II cGK also plays a role in the regulation of endochondral ossification by C-type natriuretic peptide, in renin secretion by the kidney, aldosterone secretion by the adrenal, and in the adjustment of the biological clock.


Gastroenterology | 2010

T1841 Differential Effect of NHE3 Kinase a Regulatory Protein (E3karp/NHERF2) Knockout on cAMP-, cGMP-, or [Ca2+]-Induced Inhibition of Na+/H+ Exchanger 3 (NHE3) Activity Along the Murine Intestinal Tract

Mingmin Chen; Ayhan Cinar; Sunil Yeruva; Brigitte Riederer; Anurag K. Singh; Janina Bonhagen; Mark Donowitz; Boris M. Hogema; Hugo R. de Jonge; Ursula Seidler

G A A b st ra ct s of calcitonin on ion transport in IECs. Human colonic T84 cells grown on Transwell inserts were utilized as an in-vitro model of IECs. Chloride secretion was assessed by the measurement of short circuit current (Isc) across T84 monolayers mounted in Ussing chambers. We first examined the expression of CTR in IECs. Real time QRT-PCR and western blot analysis demonstrated the expression of CTR in T84 cells. Exposure of T84 cells to calcitonin from the basolateral but not apical side significantly increased Isc (a change of 287 ± 48 μA/cm2 from the baseline). Stimulation of Isc by calcitonin was dose-dependent (1-100 nM) and was completely blocked by the CTR antagonist, CT8-32. In addition, the increase in Isc was blocked by replacing chloride in the bath solutions with equal amount of gluconate (95 ± 6% reduction, P < 0.01) and was significantly inhibited by 10 μM of the specific CFTR inhibitor, CFTR127inh, (88 ± 9% reduction, P < 0.01) indicating the involvement of CFTR chloride channel in CT-induced effects. To further investigate the signaling pathways involved, we examined calcitonin-induced Isc in the presence of the chelator of [Cai], BAPTA-AM and PKA inhibitor, H89. Preincubation with 20 μMof BAPTAAM or 10μM H89 for 45 minutes significantly reduced calcitonin-induced Isc indicating the involvement of both Ca++and PKA-dependent pathways (58±13% reduction, P < 0.01 and 55±7%, P < 0.01, respectively). Simultaneous inhibition of both Ca++ and PKA pathways had an additive effect on the CT-induced stimulation of Isc (78 ± 8% reduction, P < 0.01). In conclusion, calcitonin-induced short circuit current appears to be mediated by CTR via direct activation of the CFTR channel and is Ca++ and PKA-dependent. This novel study showing the expression of calcitonin receptor in intestinal epithelial cells provides further insights into the molecular mechanisms underlying calcitonin-induced diarrhea. (Supported by NIDDK and Dept of Veteran Affairs).


Journal of Biological Chemistry | 2004

Plasmodium falciparum-activated Chloride Channels Are Defective in Erythrocytes from Cystic Fibrosis Patients

Patrick Verloo; Clemens H. M. Kocken; Annemarie van der Wel; Ben C. Tilly; Boris M. Hogema; Maarten Sinaasappel; Alan W. Thomas; Hugo R. de Jonge


Journal of Biological Chemistry | 2003

Autophosphorylation of cGMP-dependent protein kinase type II

Arie B. Vaandrager; Boris M. Hogema; Marcel Edixhoven; Caroline M. M. van den Burg; Alice G. M. Bot; Peter Klatt; Peter Ruth; Franz Hofmann; Jozef Van Damme; Joël Vandekerckhove; Hugo R. de Jonge


Gastroenterology | 2008

749 Nherf2 Is Necessary for Basal and All Second Messenger Regulation of NHE3 Activity in Intact Mouse Ileal Na Absorptive Cells

Rakhilya Murtazina; Olga Kovbasnjuk; Yueping Chen; Boris M. Hogema; Ursula Seidler; Edward J. Weinman; Hugo R. de Jonge; Mark Donowitz


Gastroenterology | 2008

S1770 Proteome of the Small Intestinal Brush Border of the NHERF1 Knock Out Mouse: Up Regulation of Transporters and Pro-Proliferation Molecules

Mark Donowitz; Siddharth Singh; Farah F. Salahuddin; Boris M. Hogema; Marjan Gucek; Robert N. Cole; Yueping Chen; Rakhilya Murtazina; Nicholas C. Zachos; Olga Kovbasnjuk; Lynne A. Lapierre; Nellie Broere; James R. Goldenring; Hugo deJonge; Xuhang Li


Gastroenterology | 2011

Glucocorticoid-Mediated Increase in NHE3 Synthesis, Membrane Trafficking and Function is Differentially Impaired in NHERF2 Ko and NHERF3 (PDZK1) Ko Ileum

Brigitte Riederer; Anurag K. Singh; Sunil Yeruva; Ayesha Sultan; Brigitte Rausch; Regina Engelhardt; C. Chris Yun; Olivier Kocher; Mark Donowitz; Boris M. Hogema; Hugo deJonge; Ursula Seidler


Gastroenterology | 2010

T1853 NHERF1 and NHERF2 Separately Contribute to Basal and Acutely Regulated NHE3 Activity. An Exception is cAMP Inhibiton Which Can Be Mediated Either by NHERF1 or NHERF2

Vera E. Valkhoff; Rong Lin; Nicholas C. Zachos; Boyoung Cha; Tian-e Chen; Hugo R. de Jonge; Boris M. Hogema; Mark Donowitz


Gastroenterology | 2010

T1867 Proteome of the Small Intestinal Brush Border of the NHERF2 Knock out (Ko) Mouse: Changes in Transporters and Signaling Molecules

Mark Donowitz; Siddharth Singh; Prashant Singh; Molee Chakraborty; Marjan Gucek; Nicholas C. Zachos; Olga Kovbasnjuk; James R. Goldenring; Ursula Seidler; Hugo R. de Jonge; Boris M. Hogema; Xuhang Li; Rakhilya Murtazina

Collaboration


Dive into the Boris M. Hogema's collaboration.

Top Co-Authors

Avatar

Mark Donowitz

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hugo R. de Jonge

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nicholas C. Zachos

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Olga Kovbasnjuk

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hugo deJonge

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Anurag K. Singh

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marjan Gucek

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Rakhilya Murtazina

Johns Hopkins University School of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge